Maryland Statutes
§ 13-3502
Maryland § 13-3502
This text of Maryland § 13-3502 is published on Counsel Stack Legal Research, covering Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Md. Code Ann., Health - General § 13-3502 (2026).
Text
(a)The Secretary shall establish guidelines for the co–prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in § 21–2A–01 of this article.
(b)The guidelines established under subsection (a) of this section shall address the co–prescribing of opioid overdose reversal drugs for patients who are:
(1)At an elevated risk of overdose; and
(2)(i) Receiving opioid therapy for chronic pain;
(ii)Receiving a prescription for benzodiazepines; or
(iii)Being treated for opioid use disorders.
Free access — add to your briefcase to read the full text and ask questions with AI
Nearby Sections
15
Cite This Page — Counsel Stack
Bluebook (online)
Maryland § 13-3502, Counsel Stack Legal Research, https://law.counselstack.com/statute/md/ghg/13-3502.